B. Weber

发表

Treatment plan comparison of proton vs photon radiotherapy for lower-grade gliomas

P. W. Nyström, Y. Lassen-Ramshad, S. Lukacova, 2021, Physics and imaging in radiation oncology.

First clinical real-time motion-including tumor dose reconstruction during radiotherapy delivery.

J. Bertholet, P. Poulsen, M. Høyer, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer

S. Jakobsen, E. Nexo, S. Keiding, 2011, British Journal of Cancer.

Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor

E. Nexo, B. Sorensen, S. Keiding, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays

E. Nexo, A. Khalil, B. Sorensen, 2014, BMC Cancer.

Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma

S. Hamilton-Dutoit, H. Grønbæk, J. Kelsen, 2020, BMC cancer.

Clinical outcomes after stereotactic ablative radiotherapy in locally advanced cholangiocarcinoma

M. Høyer, E. Worm, B. Weber, 2021, Acta oncologica.

Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency

T. Pickles, R. Ma, B. Weber, 2015, Ocular Oncology and Pathology.

Geometric and dosimetric comparison of four intrafraction motion adaptation strategies for stereotactic liver radiotherapy

S. Nankali, P. Poulsen, M. Høyer, 2018, Physics in medicine and biology.

Growth hormone deficiency in adult survivors of childhood brain tumors treated with radiation

H. Hasle, B. Weber, M. Callesen, 2022, Endocrine connections.

Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib.

C. Demuth, B. Weber, P. Meldgaard, 2016, Lung cancer.

EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer.

E. Nexo, A. Khalil, H. Hager, 2014, Lung cancer.

EGFR CA repeat polymorphism predict clinical outcome in EGFR mutation positive NSCLC patients treated with erlotinib.

B. Weber, P. Nissen, P. Meldgaard, 2014, Lung cancer.

Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study.

M. Bøgsted, F. Mortensen, S. Detlefsen, 2020, European journal of cancer.

The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment

C. Demuth, B. Weber, P. Meldgaard, 2018, BMC Cancer.

Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.

M. Camborde, J. Hamm, R. Ma, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer

Cheryl Ho, B. Weber, R. Yuan, 2016, Journal of Neuro-Oncology.

Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer

F. Mortensen, P. Pfeiffer, B. Weber, 2021, Acta oncologica.

Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age

M. Bøgsted, P. Pfeiffer, U. Falkmer, 2021, Pancreas.

Survival and morbidity following stereotactic radiotherapy of hepatocellular carcinoma: a ten-year, single institution experience

E. Worm, G. Villadsen, B. Weber, 2021, Scandinavian journal of gastroenterology.

Hepatic regeneration following radiation-induced liver injury is associated with increased hepatobiliary secretion measured by PET in Göttingen minipigs

S. Hamilton-Dutoit, A. Alstrup, F. Mortensen, 2020, Scientific Reports.

Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas - A Single Institution Phase II Study.

C. Mar, E. Yoshida, R. Ma, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma

S. Hamilton-Dutoit, H. Grønbæk, N. Aagaard, 2020, Scandinavian journal of gastroenterology.

Pilot Study Experiences With Hyperpolarized [1‐13C]pyruvate MRI in Pancreatic Cancer Patients

Christoffer Laustsen, Steffen Ringgaard, Hans Stødkilde-Jørgensen, 2019, Journal of magnetic resonance imaging : JMRI.

Monitoring of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Sensitizing and Resistance Mutations in the Plasma DNA of Patients With Advanced Non–Small Cell Lung Cancer During Treatment With Erlotinib

E. Nexo, B. Weber, P. Meldgaard, 2014, Cancer.

A Randomized Controlled Trial of Emotion Regulation Therapy for Psychologically Distressed Caregivers of Cancer Patients

D. Mennin, A. Applebaum, R. Zachariae, 2019, JNCI cancer spectrum.

Complete Pathologic Response in Lung Tumors in Two Patients with Metastatic Non-small Cell Lung Cancer Treated with Erlotinib

E. Nexo, M. Knap, B. Weber, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A national study on the inter-observer variability in the delineation of organs at risk in the brain

C. Hansen, Y. Lassen-Ramshad, S. Lukacova, 2021, Acta oncologica.

Automatic online and real-time tumour motion monitoring during stereotactic liver treatments on a conventional linac by combined optical and sparse monoscopic imaging with kilovoltage x-rays (COSMIK)

Rune Hansen, Per R Poulsen, Morten Høyer, 2018, Physics in medicine and biology.

A Prospective Cohort Study of Gated Stereotactic Liver Radiation Therapy Using Continuous Internal Electromagnetic Motion Monitoring.

Cai Grau, Rune Hansen, Morten Høyer, 2018, International journal of radiation oncology, biology, physics.

Intrafraction tumor motion monitoring and dose reconstruction for liver pencil beam scanning proton therapy

S. Nankali, J. Bertholet, P. Poulsen, 2023, Frontiers in Oncology.

Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulations

P. Poulsen, M. Høyer, E. Worm, 2021, Physics in medicine and biology.

Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials

P. Pfeiffer, M. Mortensen, B. Weber, 2023, Current oncology.

Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring

V. Gebski, P. Keall, J. Booth, 2021, BMC cancer.

Geometric and dosimetric comparison of four intrafraction motion adaptation strategies for stereotactic liver radiotherapy

Per Rugaard Poulsen, Rune Hansen, Morten Høyer, 2018, Physics in medicine and biology.